ROSSMORE PRIVATE CAPITAL – Eli Lilly and Company Transaction History
ROSSMORE PRIVATE CAPITAL portfolio value:
$5.54M
portfolio value
ROSSMORE PRIVATE CAPITAL quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.26% | 45 shares | -1K | $323.35 | 17.14K |
| Q2 2022 | share | Increase | +1.48% | 250 shares | 719K | $324.23 | 17.10K |
| Q1 2022 | share | Increase | +3.08% | 503 shares | 310K | $286.37 | 16.85K |
| Q4 2021 | share | Increase | +0.40% | 65 shares | 754K | $277.25 | 16.34K |
| Q3 2021 | share | Decrease | -1.16% | -191 shares | -19K | $230.3 | 16.28K |
| Q2 2021 | share | Increase | +1.86% | 301 shares | 759K | $228.04 | 16.47K |
| Q1 2021 | share | Increase | +10.93% | 1.59K shares | 560K | $184.81 | 16.17K |
| Q4 2020 | share | Increase | +1.44% | 207 shares | 335K | $166.32 | 14.58K |
| Q3 2020 | share | Increase | +21.72% | 2.56K shares | 188K | $145.05 | 14.37K |
| Q2 2020 | share | Increase | +14.69% | 1.51K shares | 511K | $160.1 | 11.80K |
| Q1 2020 | share | Increase | +0.79% | 81 shares | 85K | $134.64 | 10.29K |
| Q4 2019 | share | 0.00% | 0 shares | 201K | $126.91 | 10.21K | |
| Q3 2019 | share | Increase | +37.76% | 2.8K shares | 320K | $107.36 | 10.21K |
| Q2 2019 | share | 0.00% | 0 shares | -140K | $105.74 | 7.41K | |
| Q1 2019 | share | Increase | +4.22% | 300 shares | 139K | $123.17 | 7.41K |
| Q4 2018 | share | 0.00% | 0 shares | 59K | $109.26 | 7.11K | |
| Q3 2018 | share | Increase | +46.10% | 2.24K shares | 348K | $100.8 | 7.11K |
| Q2 2018 | share | Increase | 0.00% | 4.87K shares | 416K | $79.72 | 4.87K |
| Q4 2017 | share | Increase | 0.00% | 1.28K shares | 108.86K | $77.79 | 1.28K |